Poseida Therapeutics Inc. (PSTX) Social Stream



Poseida Therapeutics Inc. (PSTX): $4.70

-0.12 (-2.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Poseida Therapeutics Inc (PSTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PSTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-12 5 $40 $19 $25.75 $4.82 434.23%
2021-12-13 4 $40 $19 $26.333 $4.82 446.33%

The Trend in the Analyst Price Target


Over the past 130 days, PSTX's average price target has gone up $0.08.

PSTX reports an average of 201.78% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 3 40 17 25.67 9.53 169.36%
2021-08-07 3 40 17 25.67 8.59 198.84%
2021-09-11 3 40 17 25.67 8.20 213.05%
2021-08-14 3 40 17 25.67 8.80 191.7%
2021-07-03 3 40 17 25.67 8.79 192.04%

PSTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 35 weeks, PSTX's average broker recommendation rating improved by 0.33.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Poseida Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 192.37% of that group.
  • To contextualize these metrics, consider that out of all US stocks, Poseida Therapeutics Inc's variance in analysts' estimates is lower than -77.65% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Poseida Therapeutics Inc's number of analysts covering the stock is greater than 65.56% of them.
  • In terms of how Poseida Therapeutics Inc fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 118.63% of that group.

Stocks similar to Poseida Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PASG, OYST, and OTLK.

Is PSTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6952 seconds.